SCHEMBL28802174

SCHEMBL28802174

O=C(C(c1cccc([N+](=O)[O-])c1F)C(Br)c1ccnc(Cl)n1)C(c1cccc([N+](=O)[O-])c1F)C(Br)c1ccnc(Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.40
TRPV1 Q8NER1 1/20 0.37
ALDH1A1 P00352 7/20 0.36
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
TDP1 Q9NUW8 4/20 0.36
PDE10A Q9Y233 1/20 0.34
PIN1 Q13526 4/20 0.34
MAPK13 O15264 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
MAPT P10636 4/20 0.32
POLB P06746 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9987869 0.81 MEN1 (0.39) TRPV1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL9986802 0.80 MAPK13 (0.38) CYP1A2TRPV1ALDH1A1KDM4EMEN1
SCHEMBL28805555 0.77 TRPV1 (0.36) CYP1A2TRPV1ALDH1A1KDM4EMEN1
SCHEMBL14867706 0.70
SCHEMBL28909321 0.69 TDP1 (0.45) CYP1A2ALDH1A1MEN1KMT2ATDP1
SCHEMBL16119496 0.69 CYP1A2 (0.47) CYP1A2ALDH1A1MEN1KMT2ATDP1
SCHEMBL9987868 0.68 MAPK13 (0.39) CYP1A2TRPV1ALDH1A1KDM4EMEN1
SCHEMBL28046049 0.67 CYP1A2 (0.44) CYP1A2ALDH1A1MEN1KMT2ATDP1
SCHEMBL27841207 0.66 TDP1 (0.46) CYP1A2ALDH1A1MEN1KMT2ATDP1
SCHEMBL31443372 0.65 KMO (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103080107-A Heteroaryl compounds and compositions as protein kinase inhibitors NOVARTIS AG 2013-05-01 CN disclosed